KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SentinelOne (S) Research & Development (2020 - 2026)

SentinelOne (S) has disclosed Research & Development for 6 consecutive years, with $83.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Research & Development rose 18.02% to $83.1 million in Q4 2025 year-over-year; TTM through Oct 2025 was $309.1 million, a 24.23% increase, with the full-year FY2025 number at $267.0 million, up 22.38% from a year prior.
  • Research & Development was $83.1 million for Q4 2025 at SentinelOne, up from $79.1 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $83.1 million in Q4 2025 to a low of $27.8 million in Q2 2021.
  • A 5-year average of $55.9 million and a median of $55.0 million in 2022 define the central range for Research & Development.
  • Peak YoY movement for Research & Development: skyrocketed 132.98% in 2021, then decreased 1.51% in 2023.
  • SentinelOne's Research & Development stood at $34.8 million in 2021, then skyrocketed by 50.21% to $52.2 million in 2022, then increased by 0.14% to $52.3 million in 2023, then surged by 34.69% to $70.5 million in 2024, then grew by 18.02% to $83.1 million in 2025.
  • Per Business Quant, the three most recent readings for S's Research & Development are $83.1 million (Q4 2025), $79.1 million (Q3 2025), and $72.3 million (Q2 2025).